bleomycin A6

08/01/1999 - "To evaluate the efficacy of boanmycin (BAM) in patients with advanced cancers. "
12/01/2012 - "Punctate calcification and dotted blood flow were seen in boanmycin hydrochloride group; however, there was massive calcification and no blood flow in the tumor in the boanmycin hydrochloride in situ gel group. "
02/01/2016 - "Hence, it is critical to clarify boanmycin potential in remodeling the tumor microenvironment after the chemotherapy treatment of tumors. "
12/01/2012 - "The tumor growth was significantly inhibited by peritumoral therapy in boanmycin hydrochloride in situ gel group with the tumor inhibitory rate of 86.76%. "
10/01/1990 - "At a tolerable dosage level, bleomycin A6 exerted remarkable growth inhibition on human colon cancer HT-29 and cecum cancer Hce-8693 xenografts (approximately 90% inhibition). "

01/01/2001 - "[Inhibitory effect of boanmycin on the growth of colon carcinoma 26 and hepatic metastasis in mice]."
01/01/2001 - "Boanmycin is highly effective in a panel of models including the subcutaneous, orthotopic, intra-hepatic transplanted tumors, and hepatic metastases of murine colon carcinoma 26."
02/01/2016 - "Boanmycin treatment for cancer chemotherapy has the remodeling ability to alter the tumor microenvironment and might contribute toward lung cancer relapse and metastasis on long-term treatment."
01/01/1995 - "The study suggests that the combination of boanmycin and minocycline may be useful for control of tumor metastasis and the inhibition of type IV collagenase expression may be involved in the mechanism of minocycline potentiation."
01/01/1995 - "Boanmycin (bleomycin A6, BAM) was found to markedly inhibit the spontaneous pulmonary metastasis of Lewis carcinoma in mice. "

12/01/2012 - "Temperature-sensitive boanmycin hydrochloride in situ gel can effectively delay the release of boanmycin hydrochloride and increase its anticancer effects for liver cancer in animal model."
12/01/1987 - "[Antitumor activity of bleomycin A6 against human liver cancer in cell culture and in nude mice]."
01/01/1991 - "[Experimental studies on the antitumor activity of monoclonal antibody--bleomycin A6 conjugate against human liver cancer]."
01/01/1991 - "Bleomycin A6 (A6), a single component of bleomycin complex, is highly active against human liver cancer cells in vitro and xenografts in nude mice. "
01/01/1991 - "These results suggest that the conjugate of monoclonal antibody and bleomycin A6 exhibits specific cytotoxicity to target liver cancer cells and the conjugate is highly effective against liver cancer xenografts in nude mice with more marked tumor inhibition than free A6 at comparable dose levels."

01/01/2001 - "[Inhibitory effect of boanmycin on the growth of colon carcinoma 26 and hepatic metastasis in mice]."
01/01/2001 - "Boanmycin is highly effective in a panel of models including the subcutaneous, orthotopic, intra-hepatic transplanted tumors, and hepatic metastases of murine colon carcinoma 26."
01/01/1995 - "Boanmycin (bleomycin A6, BAM) was found to markedly inhibit the spontaneous pulmonary metastasis of Lewis carcinoma in mice. "
01/01/2001 - "To investigate the therapeutic effect of boanmycin (BAM, bleomycin A6) on colon carcinoma 26 and its hepatic metastasis in mice. "

02/01/2001 - "Activity of boanmycin against colorectal cancer."
01/01/1993 - "[Experimental studies on therapeutic effect of rat monoclonal antibody-bleomycin A6 conjugate against human colorectal cancer]."